For more than three decades, Clayton, North Carolina has been home to Novo Nordisk's first and largest manufacturing presence in the U.S. In those 30+ years, we've expanded nine times in North Carolina, invested nearly $6 billion dollars, built and upgraded two more facilities and gone from 50 employees to more than 2,500.
Now, we're investing another $4.1 billion and adding 1,000 more jobs to build our most innovative production facility ever in the state.
Novo Nordisk establishes first manufacturing site in the U.S.
Novo Nordisk establishes first manufacturing site in the U.S.
First products to market
First products to market
Site expansions
Site expansions
New site groundbreaking
New site groundbreaking
Third site purchased
Third site purchased
Construction completed on second Clayton facility
Construction completed on second Clayton facility
First oral products to market
First oral products to market
Another record-breaking investment announced
Another record-breaking investment announced
Embedded within the fabric of Novo Nordisk's enduring commitment to North Carolina is the guiding influence of the Novo Nordisk Way. The Novo Nordisk Way is a set of guiding principles underpinning every decision we make. It inspires us to be a responsible business leader, one that is committed to increasing the talent pipeline with our local higher education partners by investing millions of dollars into education and workforce development for the life science industry.
We take great pride in our long-standing partnership with the state’s top-tier research universities and community college system, as well as civic, business, and industry organizations.